Literature DB >> 9777488

Sensorineural hearing loss caused by mitochondrial DNA mutations: special reference to the A1555G mutation.

S Usami1, S Abe, H Shinkawa, W J Kimberling.   

Abstract

Mutations in mitochondrial DNA, which are maternally inherited, have been thought to be one of the causes of sensorineural hearing loss. Two mitochondrial mutational sites (A1555G, A7445G) have been reported to be responsible for non-syndromic hearing impairments. The A1555G mutation causes increased susceptibility to aminoglycoside antibiotic-induced hearing loss as well as non-syndromic sensorineural hearing loss. Our wide screening study showed that there may be a great number of subjects within the Japanese population who have the A1555G mutation. Recent reports suggest that high-risk populations may exist throughout the world. The aminoglycoside-induced hearing loss associated with a mitochondrial mutation is commonly bilateral, symmetric, high frequency involved, and is sometimes associated with progressive sensorineural hearing loss.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777488     DOI: 10.1016/s0021-9924(98)00014-8

Source DB:  PubMed          Journal:  J Commun Disord        ISSN: 0021-9924            Impact factor:   2.288


  12 in total

1.  Minimizing the toxicity of aminoglycosides in cystic fibrosis.

Authors:  Alan R Smyth
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

2.  Ototoxicity caused by aminoglycosides.

Authors:  Maria Bitner-Glindzicz; Shamima Rahman
Journal:  BMJ       Date:  2007-10-20

Review 3.  Drug-Induced Ototoxicity: Diagnosis and Monitoring.

Authors:  Kathleen C M Campbell; Colleen G Le Prell
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

4.  Gentamicin differentially alters cellular metabolism of cochlear hair cells as revealed by NAD(P)H fluorescence lifetime imaging.

Authors:  Lyandysha V Zholudeva; Kristina G Ward; Michael G Nichols; Heather Jensen Smith
Journal:  J Biomed Opt       Date:  2015-05       Impact factor: 3.170

5.  Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.

Authors:  C G Le Prell; C Ojano-Dirain; E W Rudnick; M A Nelson; S J DeRemer; D M Prieskorn; J M Miller
Journal:  J Assoc Res Otolaryngol       Date:  2014-03-04

6.  [Mitochondrial A1555G mutation. Molecular genetic diagnosis in sporadic cases of non-syndromic hearing impairment].

Authors:  S Kupka; B Bodden-Kamps; M Baur; H P Zenner; M Pfister
Journal:  HNO       Date:  2004-11       Impact factor: 1.284

7.  Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants.

Authors:  Aline Fuchs; Lara Zimmermann; Myriam Bickle Graz; Jacques Cherpillod; Jean-François Tolsa; Thierry Buclin; Eric Giannoni
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 8.  Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions.

Authors:  Ruwen Böhm; Ingolf Cascorbi
Journal:  Front Pharmacol       Date:  2016-10-21       Impact factor: 5.810

Review 9.  Aminoglycoside-induced nephrotoxicity in children.

Authors:  Stephen J McWilliam; Daniel J Antoine; Rosalind L Smyth; Munir Pirmohamed
Journal:  Pediatr Nephrol       Date:  2016-11-15       Impact factor: 3.714

Review 10.  Towards the Prevention of Aminoglycoside-Related Hearing Loss.

Authors:  Mary E O'Sullivan; Adela Perez; Randy Lin; Autefeh Sajjadi; Anthony J Ricci; Alan G Cheng
Journal:  Front Cell Neurosci       Date:  2017-10-18       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.